Drug Discovery Chemistry Europe - 2024 - In Person

€906.29

Qty:

Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis

{"enabled":true,"emptyMessage":"","validationText":"Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis","valueAsString":"Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis","lastSetTextBoxValue":"Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis"}

Selected Conference Pricing
Basic Conference Pricing Academic - Early Bird - Registration Rate Until August 2, 2024	€799

Selected Conference Programs

C2B: AI/ML for Early Drug Discovery

None

Selected Discounts

Poster Discount

€50 off

Track Poster Detail

Track Selected

C2B: AI/ML for Early Drug Discovery

Poster Title

Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis